Kudlac J, Hanan S, McKee G L
Public Health Laboratory, Oklahoma State Department of Health, Oklahoma City 73124.
J Clin Microbiol. 1989 Jun;27(6):1303-6. doi: 10.1128/jcm.27.6.1303-1306.1989.
A standardized pool of human sera that was positive for human immunodeficiency virus type 1 (HIV-1) antibody was developed. This positive control serum was used to analyze test differences among eight laboratories, among the HIV-1 antibody test kits of three different manufacturers, among different lots of the same test kit, and among pipetting devices and techniques. The standardized pool of human sera was tested 327 times by the different laboratories. In terms of positive tests, a reproducibility of 99.69% was achieved; however, significant test variance among laboratories, among test kit lots, and among pipetting devices and techniques could be demonstrated if the tests were compared on the basis of the net positive optical density (OD) value. This value was calculated by subtracting the cutoff OD value (i.e., the value below which an OD value was considered negative for HIV-1 antibody) from the observed OD value of the standardized pool of human sera. The results obtained suggest that this strategy can be used for proficiency testing, for monitoring the quality of HIV-1 antibody enzyme-linked immunosorbent assay reagents, and for evaluating pipetting devices and techniques.
建立了一批经标准化处理的、抗人类免疫缺陷病毒1型(HIV-1)抗体呈阳性的人血清样本。该阳性对照血清用于分析八个实验室之间、三种不同制造商生产的HIV-1抗体检测试剂盒之间、同一检测试剂盒不同批次之间以及移液装置和技术之间的检测差异。不同实验室对该标准化人血清样本进行了327次检测。在阳性检测方面,重现性达到了99.69%;然而,如果根据净阳性光密度(OD)值对检测结果进行比较,就可以证明实验室之间、检测试剂盒批次之间以及移液装置和技术之间存在显著的检测差异。该值通过从标准化人血清样本的观察OD值中减去临界OD值(即OD值低于该值时被认为HIV-1抗体呈阴性)来计算。所获得的结果表明,该策略可用于能力验证、监测HIV-1抗体酶联免疫吸附测定试剂的质量以及评估移液装置和技术。